During the past decade, UCLA Center for Health Sciences conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Center for Health Sciences" #1 collaborator was "National Marrow Donor Program" with 1 trials as a collaborator, "Pediatric Blood and Marrow Transplant Consortium" with 1 trials as a collaborator and "Rare Diseases Clinical Research Network" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Center for Health Sciences" are "Acute Lymphoblastic Leukemia" (1 trials), "Acute Lymphoblastic Leukemia/Lymphoma" (1 trials), "Acute Myelogenous Leukemia" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Anemia, Aplastic" (1 trials). Many other conditions were trialed in "UCLA Center for Health Sciences" in a lesser frequency.

Most popular intervention types in "UCLA Center for Health Sciences" are "Drug" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATIR101" (1 trials), "Busulfan" (1 trials), "Cell processing for TCRαβ+/CD19+ depletion" (1 trials), "Cyclophosphamide" (1 trials) and "Cyclosporine" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Center for Health Sciences" are 4 trials for "All" genders.

Currently, there are NaN active trials in "UCLA Center for Health Sciences". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UCLA Center for Health Sciences, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Center for Health Sciences, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".